Search hospitals > Michigan > Detroit

Wayne State University

Claim this profile
Detroit, Michigan 48201
Global Leader in Newborns
Global Leader in Low Birth Weight
Conducts research for Small for Gestational Age
Conducts research for Premature Infants
Conducts research for Multiple Sclerosis
330 reported clinical trials
11 medical researchers
Photo of Wayne State University in DetroitPhoto of Wayne State University in DetroitPhoto of Wayne State University in Detroit

Summary

Wayne State University is a medical facility located in Detroit, Michigan. This center is recognized for care of Newborns, Low Birth Weight, Small for Gestational Age, Premature Infants, Multiple Sclerosis and other specialties. Wayne State University is involved with conducting 330 clinical trials across 467 conditions. There are 11 research doctors associated with this hospital, such as Zora Djuric, PhD, Anthony Lagina, MD, Seetha Shankaran, MD, and Wazim Mohamed, MD.

Top PIs

Clinical Trials running at Wayne State University

Multiple Sclerosis
Sleep Apnea
Post-Traumatic Stress Disorder
High Blood Pressure
Traumatic Stress Disorders
Obstructive Sleep Apnea
Tinnitus
Bacterial Pneumonia
Coronavirus
Immunocompromised
Image of trial facility.

Tolebrutinib

for Primary Progressive Multiple Sclerosis

Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis (PPMS) Secondary Objectives: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonance imaging (MRI) lesions, cognitive performance, physical function, and quality of life To evaluate safety and tolerability of SAR442168 To evaluate population pharmacokinetics (PK) of SAR442168 in PPMS and its relationship to efficacy and safety To evaluate pharmacodynamics of SAR442168
Recruiting1 award Phase 35 criteria
Image of trial facility.

Early Aggressive vs Traditional Therapy

for Multiple Sclerosis

FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has begun. It is unclear if, in the relapsing phase, there is an advantage of early aggressive therapy with respect to preventing long-term disability. The infectious risks and other complications associated with higher-efficacy treatments highlight the need to quantify their effectiveness in preventing disability. The TRaditional versus Early Aggressive Therapy for MS (TREAT-MS) trial is a pragmatic, randomized controlled trial that has two primary aims: 1) to evaluate, jointly and independently among patients deemed at higher risk vs. lower risk for disability accumulation, whether an "early aggressive" therapy approach, versus starting with a traditional, first-line therapy, influences the intermediate-term risk of disability, and 2) to evaluate if, among patients deemed at lower risk for disability who start on first-line MS therapies but experience breakthrough disease, those who switch to a higher-efficacy versus a new first-line therapy have different intermediate-term risk of disability.
Recruiting1 award N/A5 criteria
Image of trial facility.

Backward vs Forward Walking Training

for Multiple Sclerosis

This trial will test if practicing walking backward can help people with multiple sclerosis (MS) improve their balance and reduce their risk of falling. People with MS often have trouble with mobility and thinking, leading to frequent falls. Current methods like forward walking exercises haven't been very effective. The study will compare backward walking to forward walking to see which is better for improving motor function and preventing falls.
Recruiting1 award N/A3 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Wayne State University?
Wayne State University is a medical facility located in Detroit, Michigan. This center is recognized for care of Newborns, Low Birth Weight, Small for Gestational Age, Premature Infants, Multiple Sclerosis and other specialties. Wayne State University is involved with conducting 330 clinical trials across 467 conditions. There are 11 research doctors associated with this hospital, such as Zora Djuric, PhD, Anthony Lagina, MD, Seetha Shankaran, MD, and Wazim Mohamed, MD.
Where is Wayne State University located?
To reach Wayne State University Hospital in Detroit, Michigan: - From the Lodge Freeway (M-10), exit at Warren-Forest, proceed to the Lodge Service Drive, turn right on Warren, left on Cass, and right on Putnam to find parking structure #6. - Alternatively, access is available via I-94 (east or west), I-75 (north or south), or I-96 (east), with specific directions provided for each route.
Who should I call to ask about financial aid or insurance network?
**Wayne State University Hospital Financial Assistance and Insurance Departments Contact Information:** **Financial Assistance:** - Email: studentservice@wayne.edu - Phone: 313-577-2100 **Insurance Departments:** - Email: askhr@wayne.edu - Phone: 888-907-1433 (Businessolver's Wayne State Benefits Center) - Phone: 313-577-3000 (HR Service Center)
What insurance does Wayne State University accept?
Wayne State University offers a variety of insurance plans for its hospital services, catering to both domestic and international students. International students must have health insurance coverage throughout their program, including medical evacuation and repatriation, with the IHIP student plan by Blue Water Benefits Administration being an option. Canadian F-1 students commuting from Canada can opt out of the IHIP by showing proof of coverage through OHIP. Domestic students have access to different medical insurance options, details of which can be compared using the university's comparison chart.
What awards or recognition has Wayne State University received?
Wayne State University Hospital, located in Detroit, Michigan, is a nationally recognized center of excellence, particularly noted for its contributions to cardiovascular research. It is closely affiliated with the university's School of Medicine, which is a leader in medical research in Michigan, boasting research awards of over $183 million in the 2023 fiscal year. The university also reported significant research expenditures of $242.2 million in FY22, securing the 75th rank among public research universities for total R&D expenditures according to the National Science Foundation (NSF) in FY22.